Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery.

Abujarour R, Bennett M, Valamehr B, Lee TT, Robinson M, Robbins D, Le T, Lai K, Flynn P.

Stem Cells Transl Med. 2014 Feb;3(2):149-60. doi: 10.5966/sctm.2013-0095. Epub 2014 Jan 6.

2.

Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells.

Shoji E, Woltjen K, Sakurai H.

Methods Mol Biol. 2016;1353:89-99. doi: 10.1007/7651_2015_257.

PMID:
25971915
3.

Regeneration: making muscle from hPSCs.

Zhu X, Fu L, Yi F, Liu GH, Ocampo A, Qu J, Izpisua Belmonte JC.

Cell Res. 2014 Oct;24(10):1159-61. doi: 10.1038/cr.2014.91. Epub 2014 Jul 8.

4.

Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro.

Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, Kimura E, Sakurai H.

PLoS One. 2013 Apr 23;8(4):e61540. doi: 10.1371/journal.pone.0061540. Print 2013.

5.

Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation.

Goudenege S, Lebel C, Huot NB, Dufour C, Fujii I, Gekas J, Rousseau J, Tremblay JP.

Mol Ther. 2012 Nov;20(11):2153-67. doi: 10.1038/mt.2012.188. Epub 2012 Sep 18.

6.

Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.

Kimura E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS.

Hum Mol Genet. 2008 Aug 15;17(16):2507-17. doi: 10.1093/hmg/ddn151. Epub 2008 May 29.

7.

Reprogramming of human umbilical cord stromal mesenchymal stem cells for myogenic differentiation and muscle repair.

Kocaefe C, Balci D, Hayta BB, Can A.

Stem Cell Rev. 2010 Dec;6(4):512-22. doi: 10.1007/s12015-010-9177-7.

PMID:
20665127
8.

Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD.

Goudenege S, Pisani DF, Wdziekonski B, Di Santo JP, Bagnis C, Dani C, Dechesne CA.

Mol Ther. 2009 Jun;17(6):1064-72. doi: 10.1038/mt.2009.67. Epub 2009 Apr 7.

9.

Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discovery.

Jang J, Yoo JE, Lee JA, Lee DR, Kim JY, Huh YJ, Kim DS, Park CY, Hwang DY, Kim HS, Kang HC, Kim DW.

Exp Mol Med. 2012 Mar 31;44(3):202-13. doi: 10.3858/emm.2012.44.3.015.

10.

MYOD mediates skeletal myogenic differentiation of human amniotic fluid stem cells and regeneration of muscle injury.

Kim JA, Shon YH, Lim JO, Yoo JJ, Shin HI, Park EK.

Stem Cell Res Ther. 2013;4(6):147.

11.

Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture.

Hosoyama T, McGivern JV, Van Dyke JM, Ebert AD, Suzuki M.

Stem Cells Transl Med. 2014 May;3(5):564-74. doi: 10.5966/sctm.2013-0143. Epub 2014 Mar 21.

12.

Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells.

Shoji E, Sakurai H, Nishino T, Nakahata T, Heike T, Awaya T, Fujii N, Manabe Y, Matsuo M, Sehara-Fujisawa A.

Sci Rep. 2015 Aug 20;5:12831. doi: 10.1038/srep12831.

13.

In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantation.

Del Bo R, Torrente Y, Corti S, D'Angelo MG, Comi GP, Fagiolari G, Salani S, Cova A, Pisati F, Moggio M, Ausenda C, Scarlato G, Bresolin N.

Cell Transplant. 2001 Mar-Apr;10(2):209-21.

PMID:
11332636
14.

A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles.

Caron L, Kher D, Lee KL, McKernan R, Dumevska B, Hidalgo A, Li J, Yang H, Main H, Ferri G, Petek LM, Poellinger L, Miller DG, Gabellini D, Schmidt U.

Stem Cells Transl Med. 2016 Sep;5(9):1145-61. doi: 10.5966/sctm.2015-0224. Epub 2016 May 23.

15.

[Effects of mechanical stretch with variant frequencies on alignment and differentiation of multilayer myotubes cultured in vitro].

Huang W, Liu X, Chen R, Feng L, Liao H, Yu L, Zeng H.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Jun;26(6):735-42. Chinese.

PMID:
22792775
16.

High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.

Lattanzi L, Salvatori G, Coletta M, Sonnino C, Cusella De Angelis MG, Gioglio L, Murry CE, Kelly R, Ferrari G, Molinaro M, Crescenzi M, Mavilio F, Cossu G.

J Clin Invest. 1998 May 15;101(10):2119-28.

17.

Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells.

Maffioletti SM, Gerli MF, Ragazzi M, Dastidar S, Benedetti S, Loperfido M, VandenDriessche T, Chuah MK, Tedesco FS.

Nat Protoc. 2015 Jul;10(7):941-58. doi: 10.1038/nprot.2015.057. Epub 2015 Jun 4. Erratum in: Nat Protoc. 2015 Sep;10(9):1457.

PMID:
26042384
18.

MyoD gene suppression by Oct4 is required for reprogramming in myoblasts to produce induced pluripotent stem cells.

Watanabe S, Hirai H, Asakura Y, Tastad C, Verma M, Keller C, Dutton JR, Asakura A.

Stem Cells. 2011 Mar;29(3):505-16. doi: 10.1002/stem.598.

19.

Anchorage-dependent control of muscle-specific gene expression in C2C12 mouse myoblasts.

Milasincic DJ, Dhawan J, Farmer SR.

In Vitro Cell Dev Biol Anim. 1996 Feb;32(2):90-9.

PMID:
8907122
20.

Efficient myogenic differentiation of human adipose-derived stem cells by the transduction of engineered MyoD protein.

Sung MS, Mun JY, Kwon O, Kwon KS, Oh DB.

Biochem Biophys Res Commun. 2013 Jul 19;437(1):156-61. doi: 10.1016/j.bbrc.2013.06.058. Epub 2013 Jun 25.

PMID:
23810391

Supplemental Content

Support Center